NSAIDs in paediatrics: caution with varicella!
Tóm tắt
Anti-inflammatory drugs have been suspected on several occasions to have promoted development of bacterial infection among varicella patients. Some countries have not implemented childhood varicella vaccination. Three cases in our hospital suggested the predisposing role of NSAIDs in varicella patient deterioration. Open access to these drugs widely increases their use and patient information should be continually provided in the medical offices and at dispensing pharmacy counters. Taking account of the benefit/risk balance and applying the simple precautionary principle, it would be appropriate to be cautious about the use of NSAIDs in the paediatric population.
Tài liệu tham khảo
Sentinelles network, UMR S 707, Inserm, UPMC, InVs. 2012 Compilation. [cited 2014 Nov 6]. websenti.u707.jussieu.fr/sentiweb/document/2518.
Papaloukas O, Giannouli G, Papaevangelou V. Successes and challenges in varicella vaccine. Ther Adv Vaccines. 2014;2(2):39–55.
ANSM. Fièvre et douleur chez l’enfant atteint de varicelle: l’utilisation d’anti-inflammatoires non stéroïdiens n’est pas recommandée [Internet]. [cited 2014 Nov 6]. http://ansm.sante.fr/S-informer/Informations-de-securite-Lettres-aux-professionnels-de-sante/L-utilisation-d-anti-inflammatoires-non-steroidiens-AINS-dans-le-traitement-de-la-fievre-et-ou-de-la-douleur-n-est-pas-recommandee-chez-l-enfant-atteint-de-varicelle.
Bégaud B, Evreux JC, Jouglard J, Lagier G. Imputation of the unexpected or toxic effects of drugs. Actualization of the method used in France. Therapie. 1985;40(2):111–8.
Kaplan HB, Edelson HS, Korchak HM, Given WP, Abramson S, Weissmann G. Effects of non-steroidal anti-inflammatory agents on human neutrophil functions in vitro and in vivo. Biochem Pharmacol. 1984;33(3):371–8.
Pontes T, Antunes H. Group A beta-hemolytic streptococcal toxic shock. Acta Med Port. 2004;17(5):395–8.
Leroy S, Mosca A, Landre-Peigne C, Cosson M-A, Pons G. Ibuprofen in childhood: evidence-based review of efficacy and safety. Arch Pediatr. 2007;14(5):477–84.
Zerr DM, Alexander ER, Duchin JS, Koutsky LA, Rubens CE. A case-control study of necrotizing fasciitis during primary varicella. Pediatrics. 1999;103(4 Pt 1):783–90.
Lesko SM, O’Brien KL, Schwartz B, Vezina R, Mitchell AA. Invasive group A streptococcal infection and nonsteroidal antiinflammatory drug use among children with primary varicella. Pediatrics. 2001;107(5):1108–15.
Legras A, Giraudeau B, Jonville-Bera A-P, et al. A multicentre case-control study of nonsteroidal anti-inflammatory drugs as a risk factor for severe sepsis and septic shock. Crit Care. 2009;13(2):R43.
Stevens DL. Could nonsteroidal antiinflammatory drugs (NSAIDs) enhance the progression of bacterial infections to toxic shock syndrome? Clin Infect Dis. 1995;21(4):977–80.
Voiriot G, Dury S, Parrot A, Mayaud C, Fartoukh M. Nonsteroidal antiinflammatory drugs may affect the presentation and course of community-acquired pneumonia. Chest. 2011;139(2):387–94.
Mikaeloff Y, Kezouh A, Suissa S. Nonsteroidal anti-inflammatory drug use and the risk of severe skin and soft tissue complications in patients with varicella or zoster disease. Br J Clin Pharmacol. 2008;65(2):203–9.
Ulinski T, Bensman A. Renal complications of non-steroidal anti-inflammatories. Arch Pediatr. 2004;11(7):885–8.
Mounier G, Guy C, Berthoux F, Beyens MN, Ratrema M, Ollagnier M. Severe renal adverse events with arylcarboxylic non-steroidal anti-inflammatory drugs: results of a eight-year French national survey. Therapie. 2006;61(3):255–66.
ANSM. Mise au point sur la prise en charge de la fièvre chez l’enfant [Internet]. [cited 2014 Nov 6]. http://ansm.sante.fr/var/ansm_site/storage/original/application/8a3e72e8fec9c0f68797a73832372321.pdf.